DDI Probe Cocktail: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

14

Conditions studied

26

US states with sites

13

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Clear Cell Renal Cell Carcinoma (ccRCC)	1
Colorectal Cancer (CRC)	1
Colorectal cancer	1
Drug-Drug Interaction (DDI)	1
Head and Neck Squamous Cell Carcinoma (HNSCC)	1
Hepatocellular Carcinoma (HCC)	1
Lung cancer	1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)	1
Non-Clear Cell Renal Cell Carcinoma (nccRCC)	1
Non-small Cell Lung Cancer (NSCLC)	1
Prostate cancer	1
Renal Cell Carcinoma (RCC)	1
Solid Tumor	1
Urothelial Carcinoma (UC)	1

Recruiting trials involving DDI Probe Cocktail

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 244 locations

Common questions

How many recruiting trials involve DDI Probe Cocktail?

1 recruiting trial across 14 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.